Disrupt Podcast #16: Hear From Amedisys CEO Paul Kusserow

The 16th episode of our podcast, Disrupt, is now available! 

Since joining Amedisys (Nasdaq: AMED) in 2014, CEO Paul Kusserow has spearheaded an ambitious turnaround effort, during which time the company’s stock has climbed from around $20 per share to the $130 per share range it sits at today.

Most of Amedisys’ growth over the years has come organically, though the Baton Rouge, Louisiana-based company has been active on the M&A front as well, reflected by its two recent hospice deals.

Advertisement

Listen to this episode of Disrupt to learn:

  • What Amedisys is doing to prepare for PDGM
  • How the company has grown over the last four years
  • Why Amedisys is becoming an even bigger hospice player
  • … And much more!

Subscribe to Disrupt to be notified when new episodes are released. Listen today!

Apple Podcasts
Google Play
SoundCloud

Advertisement

Disrupt is exclusively sponsored by

Companies featured in this article: